Novartis' IFRS net income for 2022 was $6.955 billion, down 19.7% from $8.661 billion in the previous year. Revenue decreased by 2.1% to $50.545 billion from $51.626 billion a year earlier.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept